Description
Anti-Human HLA-DQ (MHC Class II) In Vivo Antibody - Low Endotoxin
Introducing the Anti-Human HLA-DQ (MHC Class II) In Vivo Antibody - Low Endotoxin from Assay Genie, a highly specific monoclonal antibody tailored for in vivo applications. This antibody is designed to target the HLA-DQ protein, a critical component in the immune response, making it an excellent choice for research in immunology and related disciplines.
Featuring a robust formulation with high purity and low endotoxin levels (<1.0 EU/mg), this mouse-derived antibody offers superior performance in ELISA, flow cytometry, immunohistochemistry, and other assays. Available in various sizes, it is stabilized in phosphate-buffered saline to ensure maximum efficacy and reliability. Enhance your research with this dependable and versatile antibody. HLA-DQ is a heterodimeric protein found on the surface of antigen-presenting cells such as B cells, dendritic cells, and macrophages. It plays a vital role in the immune system by presenting peptides derived from extracellular proteins to T-cells, thereby mediating the immune response and contributing to immune surveillance and tolerance.
| Product Name: | Anti-Human HLA-DQ (MHC Class II) In Vivo Antibody - Low Endotoxin |
| Product Code: | IVMB0132 |
| Size: | 1mg, 5mg, 25mg, 50mg, 100mg |
| Clone: | 1a3 |
| Protein: | HLA-DQ |
| Product Type: | Monoclonal Antibody |
| Synonyms: | HLA-DQ Monomorphic |
| Isotype: | Mouse IgG2a |
| Reactivity: | Human |
| Immunogen: | Unknown |
| Applications: | ELISA, FC, IP, WB |
| Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. |
| Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
| Purity: | ≥95% monomer by analytical SEC >95% by SDS Page |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
| Applications: | ELISA, FC, IP, WB |
| Recommended Usage: | FC The suggested concentration for this HLA-DQ (Clone 1a3) antibody for staining cells in flow cytometry is ≤ 1.0 µg per 106 in a volume of 100 µl or 100µl of whole blood. Titration of the reagent is recommended for optimal performance for each application. WB The suggested concentration for this HLA-DQ (Clone 1a3) antibody for use in western blotting is 1-10 µg/ml. ELISA |
| Reactivity: | Human |
| Host Species: | Mouse |
| Specificity: | Clone 1a3 recognizes a monomorphic epitope on human HLA-DQ1. It does not cross-react with HLA-DR or HLA-DP. |
| Antigen Distribution: | HLA-DQ is expressed on antigen-presenting cells, including macrophages, monocytes, DCs, and B cells, and activated T cells. |
| Immunogen: | Unknown |
| Concentration: | ≥ 5.0 mg/ml |
| Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
| Purity: | ≥95% monomer by analytical SEC >95% by SDS Page |
| Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
HLA-DQ antibody, clone 1a3, recognizes the major histocompatibility complex (MHC) class II molecule Human Leukocyte Antigen - DQ isotype (HLA-DQ). MHC class II is constitutively expressed on human professional antigen-presenting cells (APCs), including macrophages/monocytes, dendritic cells (DCs), and B cells, and is induced on T cells upon activation2. HLA-DQ consists of two transmembrane proteins, a 35 kDa α (heavy) chain and 29 kDa β (light) chain3 encoded by the HLA-DQA1 and HLA-DQB1 genes, respectively, located in the HLA complex of chromosome 6. The N-terminal α1 and β1 domains form the antigen-binding groove, which binds 13-25 aa peptides derived from exogenous antigens4. On APCs, MHC class II plays a critical role in the adaptive immune response by presenting phagocytosed antigens to helper CD4 T cells. The T cell receptor (TCR)/CD3 complex of CD4 T cells interacts with peptide-MHC class II, which induces CD4 T cell activation leading to the coordination and regulation of other effector cells. CD4 molecules also bind to MHC class II, which helps augment TCR signaling5. It has also been demonstrated that MHC class II express on activated T cells are capable of antigen presentation6 and can transduce signals into T cells, enhancing T cell proliferation and activity7. Specific alleles of HLA-DQ are associated with autoimmune diseases, including celiac disease8 and type 1 diabetes9, and graft-versus-host disease10.
| Datasheet: | View |
| Protein: | HLA-DQ |
| Ligand/Receptor: | CD3/TCR, CD4 |
| Research Area: | Immunology, Innate Immunity |
